EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors

Katarina Dibdiakova iD, Zuzana Majercikova, Tomas Galanda, Romana Richterova, Branislav Kolarovszki, Peter Racay iD, Jozef Hatok

International Journal of Molecular Sciences · 01.03.2024 · 25 (5) · 2858

DOI: 10.3390/ijms25052858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.03.2024. Verfasst von Katarina Dibdiakova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4D, 03601 Martin, Slo…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Astrocytoma. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play critical roles in regulating processes associated with malignant behavior. These endopeptidases selectively degrade components of the extracellular matrix (ECM), growth factors, and their receptors, contributing to cancer cell invasiveness and migratory characteristics by disrupting the basal membrane. However, the expression profile and role of various matrix metalloproteinases remain unclear, and only a few studies have focused on differences between diagnoses of brain tumors. Using quantitative real-time PCR analysis, we identified the expression pattern of ECM modulators (n = 10) in biopsies from glioblastoma (GBM; n = 20), astrocytoma (AST; n = 9), and meningioma (MNG; n = 19) patients. We found eight deregulated genes in the glioblastoma group compared to the benign meningioma group, with only MMP9 (FC = 2.55; p = 0.09) and TIMP4 (7.28; p < 0.0001) upregulated in an aggressive form. The most substantial positive change in fold regulation for all tumors was detected in matrix metalloproteinase 2 (MNG = 30.9, AST = 4.28, and GBM = 4.12). Notably, we observed an influence of TIMP1, demonstrating a positive correlation with MMP8, MMP9, and MMP10 in tumor samples. Subsequently, we examined the protein levels of the investigated MMPs (n = 7) and TIMPs (n = 3) via immunodetection. We confirmed elevated levels of MMPs and TIMPs in GBM patients compared to meningiomas and astrocytomas. Even when correlating glioblastomas versus astrocytomas, we showed a significantly increased level of MMP1, MMP3, MMP13, and TIMP1. The identified metalloproteases may play a key role in the process of gliomagenesis and may represent potential targets for personalized therapy. However, as we have not confirmed the relationship between mRNA expression and protein levels in individual samples, it is therefore natural that the regulation of metalloproteases will be subject to several factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsAstrocytomaHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9Tissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinases

Stichwörter der Autor:innen

brain tumorsimmunodetectionmetalloproteinasesqRT-PCRtissue inhibitors

Substanzen

Matrix Metalloproteinase 2Matrix Metalloproteinase 9Tissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinases

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4D, 03601 Martin, Slovakia.
  • Department of Pathological Physiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 11161/4C, 03601 Martin, Slovakia.
  • Department of Neurosurgery, Roosevelt Hospital, Slovak Medical University, Nam. L. Svobodu 1, 97517 Banska Bystrica, Slovakia.
  • Clinic of Neurosurgery, Jessenius Faculty of Medicine in Martin, University Hospital in Martin, Comenius University in Bratislava, Kollarova 2, 03601 Martin, Slovakia.

ORCID-Profile: Katarina Dibdiakova, Peter Racay

Förderung

  • Slovak Research and Development Agency

Zitieren

APA

Dibdiakova, K., Majercikova, Z., Galanda, T., Richterova, R., Kolarovszki, B., Racay, P., & Hatok, J. (2024). Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors. International Journal of Molecular Sciences, 25(5), 2858. https://doi.org/10.3390/ijms25052858

Vancouver

Dibdiakova K, Majercikova Z, Galanda T, Richterova R, Kolarovszki B, Racay P, et al. Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors. International Journal of Molecular Sciences. 2024;25(5):2858. doi:10.3390/ijms25052858

BibTeX
@article{Dibdiakova2024,
  author = {Dibdiakova, Katarina and Majercikova, Zuzana and Galanda, Tomas and Richterova, Romana and Kolarovszki, Branislav and Racay, Peter and Hatok, Jozef},
  title = {Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2858},
  doi = {10.3390/ijms25052858}
}
Kostenlos starten →